IP Library Granted Patent US 9,061,075
Granted Patent B2
US 9,061,075 · App. 11/900,776 · Granted Jun 23, 2015

Bone delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,061,075
App. No.
11/900,776
Granted
Jun 23, 2015
Kind
B2
Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

Claims (39)

1. A method of assembling an implantable device for delivering one or more biologically active molecules to a subject, comprising:

identifying the one or more biologically active molecules,

selecting one or more devices at least partially constructed of anorganic bone and including a natural internal cavity therein;

micromachining the one or more devices to re-shape the natural internal cavity thereof;

micromachining the one or more devices to form one or more openings therein;

providing the one or more biologically active molecules to the one or more devices; and

closing the one or more openings with a layer of confluent cells prior to implanting the device in the subject.

2. The method of claim 1 , wherein discrete parts of at least one of the one or more devices include the anorganic bone.

3. The method of claim 1 , wherein micromachining the one or more devices to re-shape the natural internal cavity thereof comprises:

micromachining the one or more devices with a focused beam machine to re-shape the natural internal cavity.

4. The method of claim 1 , wherein selecting one or more devices constructed of anorganic bone comprises:

selecting the one or more devices constructed of anorganic bone having a semi-permeable component lining the internal cavity; and

providing the one or more biologically active molecules to the internal cavity.

5. The method of claim 1 , further comprising:

selecting one or more semi-permeable components; and

providing the one or more semi-permeable components to the internal cavity of the one or more devices.

6. The method of claim 1 , wherein selecting one or more devices constructed of anorganic bone comprises:

Selecting the one or more devices constructed of anorganic bone having a semi-permeable component surrounding the anorganic bone; and

providing the one or more biologically active molecules to the internal cavity.

7. The method of claim 1 , further comprising:

selecting one or more semi-permeable components; and

surrounding the anorganic bone with the one or more semi-permeable components.

8. The method of claim 1 , further comprising:

identifying one or more living cells or tissues to provide the one or more biologically active molecules; and

providing the one or more living cells or tissues to the micromachined natural internal cavity.

9. The method of claim 1 , wherein providing the one or more biologically active molecules to the one or more devices comprises:

providing one or more living cells or tissues to the one or more devices, wherein the one or more living cells or tissues are engineered to release the one or more biologically active molecules, and wherein the one or more biologically active molecules are selected to partially or completely modify bone restructuring.

10. The method of claim 1 , wherein providing the one or more biologically active molecules to the one or more devices comprises:

providing the one or more biologically active molecules to the exterior of the anorganic bone.

11. The method of claim 1 , further comprising: treating the anorganic bone to at least partially prevent restructuring.

12. The method of claim 1 , further comprising: treating the anorganic bone to enhance restructuring.

13. The method of claim 1 , further comprising: treating the anorganic bone to at least partially prevent resorption.

14. The method of claim 1 , further comprising: treating the anorganic bone to enhance resorption.

15. The method of claim 1 , wherein providing the one or more biologically active molecules to the one or more devices comprises:

providing the one or more biologically active molecules to the micromachined natural internal cavity through one or more closable openings.

16. The method of claim 1 , wherein selecting one or more of the devices at least partially constructed of anorganic bone comprises:

selecting the one or more of the devices at least partially constructed of anorganic bone, wherein the anorganic bone is autologous with respect to the subject.

17. The method of claim 8 , wherein the layer of confluent cells comprises the one or more living cells or tissues to provide the one or more biologically active molecules.

18. The method of claim 9 , wherein the layer of confluent cells comprises the one or more living cells or tissues engineered to release the one or more biologically active molecules.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2014
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 033974/0983 →